Ads
related to: cll 20 year survival rate- CLL/SLL Dosing Guidelines
Get Dosing & Prescribing Info
For A CLL Treatment.
- CLL/SLL Efficacy Data
Find Data From Clinical
Trials Of A CLL/SLL Treatment
- Educational Materials
Find A Selection Of Resources To
Help Your Patients With CLL
- Mechanism Of Action
Learn More About Treatment-Related
Lymphocytosis In A CLL Trial
- Patient Support Program
Offers Information & Resources Your
Patients May Need During Treatment.
- CLL/SLL Safety Data
Find Important Safety
Information Of A CLL/SLL Treatment
- CLL/SLL Dosing Guidelines
Search results
Results from the WOW.Com Content Network
Treatment. Watchful waiting, chemotherapy, immunotherapy [4] [5] Prognosis. Five-year survival ~88% (US) [3] Frequency. 904,000 (2015) [6] Deaths. 60,700 (2015) [7] Chronic lymphocytic leukemia ( CLL) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell ).
About 1-10% of CLL/SLLs develop a Richter's transformation at a rate of 0.5–1% per year. In earlier studies, the transformed disease was reported to be far more aggressive than CLL/SLL with overall median survival times (i.e. times in which 50% of cases remain alive) between 1.1 and 16.3 months.
Chronic lymphocytic leukemia (CLL) most often affects adults over the age of 55. It sometimes occurs in younger adults, but it almost never affects children. Two-thirds of affected people are men. The five-year survival rate is 85%. It is incurable, but there are many effective treatments.
Overall median survival was 8.12 years with survival decreasing with age from 12.4 years for patients <40 to 5.2 years for patients of 60 years or older. Risk of its recurrence or progression to overt multiple myeloma within 3 years is ~10%.
The survival rate for children under the age of 5 years with ALL was 94% during the same time period. Prognostic factors in ALL: Age at diagnosis: Children between the ages of 1–9 years with B-cell ALL (a specific type of ALL) have better cure rates than children less than 1 year old or over 10 years old. This does not seem to matter in T ...
The five-year survival rate in the United States is 88.4%. FL is the most prevalent form of indolent lymphoma, accounting for 70% of indolent cases and 20–30% of all non-Hodgkin lymphoma cases, with a yearly incidence of 1.6 to 3.1 per 100,000.
Ads
related to: cll 20 year survival rate